Key facts
- LabVoice’s last known valuation is $10.0M (Jun 2022).
- It has raised $3.7M across 2 recorded rounds; the latest was Seed Round ($1.2M) in Nov 2024.
- Notable investors include BroadOak Capital Partners, Merck.
- LabVoice has filed 2 Form Ds with the SEC since 2022, most recently Apr 2025 ($700K sold to 4 investors).
- Status: Privately Held (backing).
Investors
2- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for LabVoice
Funding rounds
2 roundsAbout LabVoice
Developer of a hands-free voice assistant designed to enhance efficiency in scientific laboratories. The company's platform offers a low-code for visual modeling of processes, a digital lab assistant for hands-free data capture and instrument control and integration capabilities with existing lab infrastructure, enabling scientists and researchers to streamline operations, improve data standardization and increase productivity.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2017
- Employees
- 15
- Website
- labvoice.ai/
- Ownership
- Privately Held (backing)
LabVoice doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in LabVoice shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on LabVoice in its N-PORT filings yet. We sweep new filings monthly.